Denis Fouque
Fouque, Denis, 1960-...., médecin
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Fouque, Denis 1960-...
VIAF ID: 197806647 (Personal)
Permalink: http://viaf.org/viaf/197806647
Preferred Forms
-
100 0 _
‡a
Denis Fouque
-
100 1 _ ‡a Fouque, Denis ‡d (1960- ).
-
100 1 _
‡a
Fouque, Denis
‡d
1960-...
-
100 1 _
‡a
Fouque, Denis,
‡d
1960-....,
‡c
médecin
4xx's: Alternate Name Forms (5)
Works
| Title | Sources |
|---|---|
| Administration intraveineuse continue d'acides aminés et synthèse protéique musculaire chez l'homme : études temps- et dose-réponse |
|
| ANALYSE CRITIQUE DES EFFETS DES RESTRICTIONS PROTIDIQUES AU COURS DE L'INSUFFISANCE RENALE CHRONIQUE PRE-TERMINALE |
|
| Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease |
|
| Editorial: a new era in anti-neutrophil cytoplasmic antibody vasculitis |
|
| The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial. |
|
| Effets métaboliques de la diminution de la production intestinale du P-Cresyl sulfate chez les souris : étude in vivo |
|
| Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement |
|
| [European recommendations for good practice in hemodialysis. Part two] |
|
| Evaluation de la chirurgie d'auto-transplantation rénale chez les patients atteints de Loin Pain Hematuria Syndrome |
|
| French law: what about a reasoned reimbursement of serum vitamin D assays? |
|
| The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP) |
|
| Growth hormone induces anabolism in malnourished maintenance haemodialysis patients. |
|
| [HAS report on vitamin D measurement: don't go from an extreme situation to another as extreme situation] |
|
| Have recommended protein and phosphate intake recently changed in maintenance hemodialysis? |
|
| Hépato-gastroentérologie Chirurgie viscérale et cardiothoracique / Néphrologie / Urologie |
|
| [How to effectively control inflammation and the nutritional status of dialysis patients?] |
|
| Human uremic plasma and not urea induces exuberant secretion of leptin in 3T3-L1 adipocytes. |
|
| Impact des variations de l'index de masse corporelle sur la survie des sujets âgés en hémodialyse |
|
| Impact of BMI Variations on Survival in Elderly Hemodialysis Patients. |
|
| In chronic kidney disease, serum α-Klotho is related to serum bicarbonate and proteinuria |
|
| [Insulin resistance and inflammation in chronic kidney diseases] |
|
| Intérêt de la vitamine D libre (free vitamin D) dans l'insuffisance rénale chronique |
|
| Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure. |
|
| Is a body mass index of 23 kg/m² a reliable marker of protein-energy wasting in hemodialysis patients? |
|
| Maladie rénale et obésité : description anatomoclinique de la diversité des atteintes rénales = idney disease in the setting of obesity : clinicopathological description of the variety of renal lesions |
|
| Maladies rénales : guide pratique de nutrition |
|
| Malnutrition in hemodialysis diabetic patients: evaluation and prognostic influence. |
|
| LE MELPHALAN A DOSE INTERMEDIAIRE : ALTERNATIVE THERAPEUTIQUE AU TRAITEMENT DU MYELOME AVEC INSUFFISANCE RENALE |
|
| Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure |
|
| Metabolic effect of omega 3 fatty acids in health and chronic kidney disease. |
|
| Mineral and bone metabolism in dialysis: towards unified patient care? |
|
| Mineral and bone status in French maintenance hemodialysis patients: a comparison of June 2005 and June 2008 |
|
| Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis |
|
| Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges |
|
| New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanoma. |
|
| Nutrition en néphrologie : théorie et pratiques |
|
| Nutrition et insuffisance rénale chronique recommandations cliniques = idney disease outcomes quality initiative K/DOQI |
|
| Outcome research, nutrition, and reverse epidemiology in maintenance dialysis patients |
|
| p-Cresyl sulfate promotes insulin resistance associated with CKD |
|
| Physical activity and energy expenditure in haemodialysis patients: an international survey |
|
| Physiopathologie de l'insulin-like growth factor (IGF)-1 en insuffisance rénale chronique humaine : applications thérapeutiques |
|
| Plant-based diets to manage the risks and complications of chronic kidney disease |
|
| Predictive factors of renal involvement in cryoglobulinaemia: a retrospective study of 153 patients |
|
| Preserved residual renal function is associated with lower oxidative stress in peritoneal dialysis patients. |
|
| Prise en charge de la maladie minérale et osseuse des patients hémodialysés en France : résultats de l'observatoire national du métabolisme phosphocalcique |
|
| Protein-restricted diets plus keto/amino acids--a valid therapeutic approach for chronic kidney disease patients. |
|
| Recurrent idiopathic thrombotic thrombocytopenic purpura: a role for vaccination in disease relapse? |
|
| The relation between renal function and serum sclerostin in adult patients with CKD. |
|
| Renal nutrition: progress on fast track |
|
| Renal perfusion: noninvasive measurement with multidetector CT versus fluorescent microspheres in a pig model |
|
| Risk profile, quality of life and care of patients with moderate and advanced CKD : The French CKD-REIN Cohort Study. |
|
| [Secondary hyperparathyroidism and anemia. Effects of a calcimimetic on the control of anemia in chronic hemodialysed patients. Pilot Study] |
|
| Serum creatinine improves body mass index survival prediction in hemodialysis patients: a 1-year prospective cohort analysis from the ARNOS study |
|
| Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction. |
|
| Severe tubulointerstitial nephritis: tracking tuberculosis even in the absence of renal granuloma |
|
| [Should we still prescribe a low protein diet in chronic kidney disease?] |
|
| Source and Composition in Amino Acid of Dietary Proteins in the Primary Prevention and Treatment of CKD |
|
| To supplement or not: that is the question |
|
| The ubiquitous nature and elusive role of phosphorus and vascular calcification |
|
| Underreporting of energy intake in maintenance hemodialysis patients: a cross-sectional study |
|
| Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life. |
|
| Use of handgrip strength in the assessment of the muscle function of chronic kidney disease patients on dialysis: a systematic review. |
|
| Vegetarianism: advantages and drawbacks in patients with chronic kidney diseases |
|
| [Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement] |
|
| [What is the benefit of the new European nutritional guidelines for dialysis?] |
|
| White adipose tissue overproduces the lipid-mobilizing factor zinc α2-glycoprotein in chronic kidney disease. |
|
| Why is the diet intervention so critical during chronic kidney disease? |
|
| Wytyczne Praktyki Klinicznej dotyczące postępowania u pacjentów w podeszłym wieku z przewlekłą chorobą nerek (PCHN) w stadium 3b lub wyższym (eGFR<45ml/min/1,73 m2) = Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45mL/min/1.73 m2) |
|
| Zinc deficiency in chronic kidney disease: is there a relationship with adipose tissue and atherosclerosis? |
|
| Zinc-α2-glycoprotein: is there association between this new adipokine and body composition in hemodialysis patients? |
|
